Literature DB >> 21248740

Genome-wide association study confirms extant PD risk loci among the Dutch.

Javier Simón-Sánchez1, Jacobus J van Hilten, Bart van de Warrenburg, Bart Post, Henk W Berendse, Sampath Arepalli, Dena G Hernandez, Rob M A de Bie, Daan Velseboer, Hans Scheffer, Bas Bloem, Karin D van Dijk, Fernando Rivadeneira, Albert Hofman, André G Uitterlinden, Patrizia Rizzu, Zoltan Bochdanovits, Andrew B Singleton, Peter Heutink.   

Abstract

In view of the population-specific heterogeneity in reported genetic risk factors for Parkinson's disease (PD), we conducted a genome-wide association study (GWAS) in a large sample of PD cases and controls from the Netherlands. After quality control (QC), a total of 514,799 SNPs genotyped in 772 PD cases and 2024 controls were included in our analyses. Direct replication of SNPs within SNCA and BST1 confirmed these two genes to be associated with PD in the Netherlands (SNCA, rs2736990: P = 1.63 × 10(-5), OR = 1.325 and BST1, rs12502586: P = 1.63 × 10(-3), OR = 1.337). Within SNCA, two independent signals in two different linkage disequilibrium (LD) blocks in the 3' and 5' ends of the gene were detected. Besides, post-hoc analysis confirmed GAK/DGKQ, HLA and MAPT as PD risk loci among the Dutch (GAK/DGKQ, rs2242235: P = 1.22 × 10(-4), OR = 1.51; HLA, rs4248166: P = 4.39 × 10(-5), OR = 1.36; and MAPT, rs3785880: P = 1.9 × 10(-3), OR = 1.19).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248740      PMCID: PMC3110043          DOI: 10.1038/ejhg.2010.254

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  66 in total

1.  The tau A0 allele in Parkinson's disease.

Authors:  L I Golbe; A M Lazzarini; J R Spychala; W G Johnson; E S Stenroos; M H Mark; J I Sage
Journal:  Mov Disord       Date:  2001-05       Impact factor: 10.338

2.  Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.

Authors:  N Khan; E Graham; P Dixon; C Morris; A Mander; D Clayton; J Vaughan; N Quinn; A Lees; S Daniel; N Wood; R de Silva
Journal:  Ann Neurol       Date:  2001-05       Impact factor: 10.422

3.  Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan.

Authors:  Y Izumi; H Morino; M Oda; H Maruyama; F Udaka; M Kameyama; S Nakamura; H Kawakami
Journal:  Neurosci Lett       Date:  2001-03-09       Impact factor: 3.046

4.  BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B-cell growth.

Authors:  T Kaisho; J Ishikawa; K Oritani; J Inazawa; H Tomizawa; O Muraoka; T Ochi; T Hirano
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

5.  alpha-Synuclein gene haplotypes are associated with Parkinson's disease.

Authors:  M Farrer; D M Maraganore; P Lockhart; A Singleton; T G Lesnick; M de Andrade; A West; R de Silva; J Hardy; D Hernandez
Journal:  Hum Mol Genet       Date:  2001-08-15       Impact factor: 6.150

6.  Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography study.

Authors:  P Piccini; P K Morrish; N Turjanski; G V Sawle; D J Burn; R A Weeks; M H Mark; D M Maraganore; A J Lees; D J Brooks
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

7.  alpha-Synuclein and Parkinson disease susceptibility.

Authors:  S Winkler; J Hagenah; S Lincoln; M Heckman; K Haugarvoll; K Lohmann-Hedrich; V Kostic; M Farrer; C Klein
Journal:  Neurology       Date:  2007-09-13       Impact factor: 9.910

8.  Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.

Authors:  Cyrus P Zabetian; Carolyn M Hutter; Stewart A Factor; John G Nutt; Donald S Higgins; Alida Griffith; John W Roberts; Berta C Leis; Denise M Kay; Dora Yearout; Jennifer S Montimurro; Karen L Edwards; Ali Samii; Haydeh Payami
Journal:  Ann Neurol       Date:  2007-08       Impact factor: 10.422

9.  The Rotterdam Study: objectives and design update.

Authors:  Albert Hofman; Monique M B Breteler; Cornelia M van Duijn; Gabriel P Krestin; Huibert A Pols; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Johannes R Vingerling; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2007-10-23       Impact factor: 8.082

10.  Discerning the ancestry of European Americans in genetic association studies.

Authors:  Alkes L Price; Johannah Butler; Nick Patterson; Cristian Capelli; Vincenzo L Pascali; Francesca Scarnicci; Andres Ruiz-Linares; Leif Groop; Angelica A Saetta; Penelope Korkolopoulou; Uri Seligsohn; Alicja Waliszewska; Christine Schirmer; Kristin Ardlie; Alexis Ramos; James Nemesh; Lori Arbeitman; David B Goldstein; David Reich; Joel N Hirschhorn
Journal:  PLoS Genet       Date:  2007-11-19       Impact factor: 5.917

View more
  101 in total

1.  Genome-wide assessment of Parkinson's disease in a Southern Spanish population.

Authors:  Sara Bandrés-Ciga; Timothy Ryan Price; Francisco Javier Barrero; Francisco Escamilla-Sevilla; Javier Pelegrina; Sampath Arepalli; Dena Hernández; Blanca Gutiérrez; Jorge Cervilla; Margarita Rivera; Alberto Rivera; Jing-Hui Ding; Francisco Vives; Michael Nalls; Andrew Singleton; Raquel Durán
Journal:  Neurobiol Aging       Date:  2016-06-11       Impact factor: 4.673

Review 2.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  Accurate prediction of a minimal region around a genetic association signal that contains the causal variant.

Authors:  Zoltán Bochdanovits; Javier Simón-Sánchez; Marianne Jonker; Witte J Hoogendijk; Aad van der Vaart; Peter Heutink
Journal:  Eur J Hum Genet       Date:  2013-06-05       Impact factor: 4.246

Review 4.  Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration.

Authors:  Fred Yeboah; Tae-Eun Kim; Anke Bill; Ulf Dettmer
Journal:  Neurobiol Dis       Date:  2019-07-24       Impact factor: 5.996

Review 5.  Parkinson's disease: proteinopathy or lipidopathy?

Authors:  Saranna Fanning; Dennis Selkoe; Ulf Dettmer
Journal:  NPJ Parkinsons Dis       Date:  2020-01-03

Review 6.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

Review 7.  The genetics of Parkinson's disease: progress and therapeutic implications.

Authors:  Andrew B Singleton; Matthew J Farrer; Vincenzo Bonifati
Journal:  Mov Disord       Date:  2013-01       Impact factor: 10.338

8.  The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease.

Authors:  Colton Linnertz; Michael W Lutz; John F Ervin; Jawara Allen; Natalie R Miller; Kathleen A Welsh-Bohmer; Allen D Roses; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2014-04-28       Impact factor: 6.150

Review 9.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

10.  Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening.

Authors:  Michael Bidinosti; Derya R Shimshek; Brit Mollenhauer; David Marcellin; Tatjana Schweizer; Gregor P Lotz; Michael G Schlossmacher; Andreas Weiss
Journal:  J Biol Chem       Date:  2012-07-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.